Enantioselective determination of cetirizine in human plasma by normal-phase liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 32, 2010, Pages 3351-3357

  Kang, Seung Woo ^a,c   Jang, Hae Jong ^a   Moore, Victor S ^a   Park, Ji Young ^b   Kim, Kyoung Ah ^b   Youm, Jeong Rok ^c   Han, Sang Beom ^c  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b Korea University College of Medicine   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

Enantioselective; Levocetirizine; Normal phase liquid chromatography; Pharmacokinetic study; Tandem mass spectrometry

Indexed keywords

ENANTIOSELECTIVE; LEVOCETIRIZINE; PHARMACOKINETIC STUDY; PHASE LIQUIDS; TANDEM MASS SPECTROMETRY;

ACETIC ACID; ACETONITRILE; ATMOSPHERIC CHEMISTRY; ATMOSPHERIC IONIZATION; ATMOSPHERIC PRESSURE; DICHLOROMETHANE; DRUG PRODUCTS; ETHANOL; HEXANE; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; LIQUIDS; MASS SPECTROMETRY; ORGANIC POLYMERS; PHARMACOKINETICS; PHASE INTERFACES; PLASMA (HUMAN); SOLVENT EXTRACTION;

CHROMATOGRAPHY;

ACETIC ACID; ACETONITRILE; ALCOHOL; CETIRIZINE; DEXTROCETIRIZINE; DICHLOROMETHANE; DIETHYLAMINE; HEXANE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCETIRIZINE; LEVOCETIRIZINE D8; PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; ATMOSPHERIC PRESSURE CHEMICAL IONIZATION TANDEM MASS SPECTROMETRY; BLOOD SAMPLING; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; ENANTIOMER; ENANTIOSELECTIVITY; HUMAN; HUMAN EXPERIMENT; KOREA; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MAXIMUM PLASMA CONCENTRATION; MULTIPLE REACTION MONITORING; NORMAL HUMAN; PHARMACOLOGICAL PARAMETERS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN PRECIPITATION; REACTOR MONITORING; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

CETIRIZINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 78649818565     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.10.019     Document Type: Article

References (55)

1. Juhlin L., Devos C., Rihoux J.P. J. Allerg. Clin. Immun. 1987, 80:599.
2. Coulie P.J., Ghys L., Rihoux J.P. J. Int. Med. Res. 1991, 19:174.
3. Eichelbaum M., Branch S., Testa B., Somogyi A. Stereochemical Aspects of Drug Action and Disposition 2003, Springer Verlag.
4. Tillement J.P., Testa B., Bree F. Biochem. Pharmacol. 2003, 66:1123.
5. Wood S.G., John B.A., Chasseaud L.F., Yeh J., Chung M. Ann. Allerg. 1987, 59:31.
6. Pandya K.K., Bangaru R.A., Gandhi T.P., Modi I.A., Modi R.I., Chakravarthy B.K. J. Pharm. Pharmacol. 1996, 48:510.
7. Baltes E., Coupez R., Brouwers L., Gobert J. J. Chromatogr. Biomed. 1988, 430:149.
8. Papich M.G., Schooley E.K., Reinero C.R. Am. J. Vet. Res. 2008, 69:670.
9. Harahap Y., Prasaja B., Indriati E., Lusthom W. Int. J. Clin. Pharm. Th. 2008, 46:268.
10. Bizikova P., Papich M.G., Olivry T. Vet. Dermatol. 2008, 19:348.
11. Birajdar A.S., Meyyanathan S.N., Raja R.B., Krishanaveni N., Suresh B. Acta Chromatogr. 2008, 20:411.
12. Bhatia N.M., Ganbavale S.K., Bhatia M.S., More H.N., Kokil S.U. Indian J. Pharm. Sci. 2008, 70:603.
13. Arayne M.S., Sultana N., Nawaz M. J. Anal. Chem. 2008, 63:881.
14. Kowalski P., Plenis A. Biomed. Chromatogr. 2007, 21:903.
15. Peytavin G., Gautran C., Otoul C., Cremieux A.C., Moulaert B., Delatour F., Melac M., Strolin-Benedetti M., Farinotti R. Eur. J. Clin. Pharmacol. 2005, 61:267.
16. Kim C.K., Yeon K.J., Ban E., Hyun M.J., Kim J.K., Kim M.K., Jin S.E., Park J.S. J. Pharmaceut. Biomed. 2005, 37:603.
17. Liu Q., Zhang Z., Bo H., Sheldon R.A. Chromatographia 2002, 56:233.
18. Grumetto L., Cennamo G., Del Prete A., La Rotonda M.I., Barbato F. Clin. Pharmacokinet. 2002, 41:525.
19. Macek J., Ptacek P., Klima J. J. Chromatogr. B 1999, 736:231.
20. CondinoNeto A., Muscara M.N., Bozza P.T., CastroFariaNeto H.C., DeNucci G. Int. J. Clin. Pharm. Th. 1996, 34:96.
21. Muscara M.N., Denucci G. Int. J. Clin. Pharm. Th. 1995, 33:27.
22. Choi S.O., Lee S.H., Kong H.S., Kim E.J., Choo H.Y. Arch. Pharm. Res. 2000, 23:178.
23. Choi S.O., Lee S.H., Kong H.S., Kim E.J., Choo H.Y. J. Chromatogr. B: Biomed. Sci. Appl. 2000, 744:201.
24. Baltes E., Coupez R., Giezek H., Voss G., Meyerhoff C., Strolin Benedetti M. Fund. Clin. Pharmacol. 2001, 15:269.
25. Hammad S.F., Mabrouk M.M., Habib A., Elfatatry H., Kishikawa N., Nakashima K., Kuroda N. Biomed. Chromatogr. 2007, 21:1030.
26. Benedetti M.S., Whomsley R., Mathy F.X., Jacques P., Espie P., Canning M. Fund. Clin. Pharmacol. 2008, 22:19.
27. Chou Y.W., Huang W.S., Ko C.C., Chen S.H. J. Sep. Sci. 2008, 31:845.
28. Van Eeckhaut A., Michotte Y. Electrophoresis 2006, 27:2376.
29. Mikus P., Valaskova I., Havranek E. J. Sep. Sci. 2005, 28:1278.
30. Chandrasekar M.J.N., Chandrasekar A.R., Krishnaraj K., Muralidharan S., Rajan S., Suresh B. Asian J. Chem. 2009, 21:5821.
31. Rudaz S., Souverain S., Schelling C., Deleers M., Klomp A., Norris A., Vu T.L., Ariano B., Veuthey J.L. Anal. Chim. Acta 2003, 492:271.
32. Petersen L.J., Church M.K., Rihoux J.P., Skov P.S. Allergy 1999, 54:607.
33. Morita M.R., Berton D., Boldin R., Barros F.A.P., Meurer E.C., Amarante A.R., Campos D.R., Calafatti S.A., Pereira R., Abib E., Pedrazolli J. J. Chromatogr. B 2008, 862:132.
34. Apostolou C., Kousoulos C., Dotsikas Y., Loukas Y.L. Biomed. Chromatogr. 2008, 22:1393.
35. Ma M., Feng F., Sheng Y.L., Cui S.J., Liu H. J. Chromatogr. B 2007, 846:105.
36. Tan Z.R., Ouyang D.S., Zhou G., Wang L.S., Li Z., Wang D., Zhou H.H. J. Pharmaceut. Biomed. 2006, 42:207.
37. Gupta A., Chatelain P., Massingham R., Jonsson E.N., Hammarlund-Udenaes M. Drug Metab. Dispos. 2006, 34:318.
38. Qi S., Junga H., Yong T., Li A.C., Addison T., McCort-Tipton M., Beato B., Weng N.D. J. Chromatogr. B 2005, 814:105.
39. Gupta A., Jansson B., Chatelaine P., Massingham R., Hammarlund-Udenaes M. Rapid Commun. Mass Spectrom. 2005, 19:1749.
40. Li A.C., Junga H., Shou W.Z., Bryant M.S., Jiang X.Y., Weng N.D. Rapid Commun. Mass Spectrom. 2004, 18:2343.
41. Eriksen H., Houghton R., Green R., Scarth J. Chromatographia 2002, 55:S145.
42. de Jager A.D., Hundt H.K.L., Swart K.J., Hundt A.F., Els J. J. Chromatogr. B 2002, 773:113.
43. Gergov M., Robson J.N., Ojanpera I., Heinonen O.P., Vuori E. Forensic Sci. Int. 2001, 121:108.
44. Nguyen H.P., Schug K.A. J. Sep. Sci. 2008, 31:1465.
45. Wistuba D. J. Chromatogr. A 2010, 1217:941.
46. Zhang T., Nguyen D., Franco P. J. Chromatogr. A 2010, 1217:1048.
47. Trivedi R.K., Layek B., Kumar T.S., Vittal S., Ganneboina R., Dubey P.K., Mullangi R., Srinivas N.R. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2007, 860:227.
48. Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDR), Center for Veterinary Medicine (CVM), BP, May 2001. http://www.fda.gov/cder/guidance/4252fnl.htm.
49. Van Eeckhaut A., Lanckmans K., Sarre S., Smolders I., Michotte Y. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:2198.
50. Okamoto Y., Ikai T. Chem. Soc. Rev. 2008, 37:2593.
51. Zhang Y., Wu D., Wang-Iverson D., Tymiak A. Drug discovery today 2005, 10:571.
52. Cai S.S., Hanold K.A., Syage J.A. Anal. Chem. 2007, 79:2491.
53. Aboul-Enein H., Ali I. Chiral Separations: Methods and Protocols 2003, 83. Humana Press, Totowa, NJ, USA. G. Gübitz, M.G. Schmid (Eds.).
54. Lynam K.G., Stringham R.W. Chirality 2006, 18:1.
55. Hanold K.A., Fischer S.M., Cormia P.H., Miller C.E., Syage J.A. Anal. Chem. 2004, 76:2842.